SCHEMBL697080

SCHEMBL697080

CCCOCc1ccc(C=O)o1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.43
MAPT P10636 4/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
STAT1 P42224 1/20 0.43
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 1/20 0.38
KDM4E B2RXH2 3/20 0.36
HSP90AA1 P07900 1/20 0.36
POLB P06746 3/20 0.36
TP53 P04637 2/20 0.36
HPGD P15428 2/20 0.36
MDM2 Q00987 1/20 0.35
ALOX5 P09917 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135809 0.90 ALDH1A1 (0.47) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL17693406 0.89 ALDH1A1 (0.57) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL14060191 0.87 SMN1; SMN2 (0.44) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL1664842 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL2900095 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL25207012 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL2894583 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL2899979 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL14715643 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL2896615 0.87 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112830916-B Preparation method of 2, 5-furandicarboxylic acid under mild condition 中国科学院宁波材料技术与工程研究所 2021-08-13 CN claimed
CN-117619441-A Difunctional carbon-based solid acid catalyst, preparation method and application 淮阴师范学院 2024-03-01 CN disclosed
US-11655227-B2 Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant EASTMAN CHEMICAL COMPANY (US) 2023-05-23 US disclosed
US-11655227-B2 Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant EASTMAN CHEMICAL COMPANY (US) 2023-05-23 US disclosed
US-10882032-B2 Furan-2,5-dicarboxylic acid purge process EASTMAN CHEMICAL COMPANY (US) 2021-01-05 US disclosed
US-10875834-B2 Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives VIRGINIA COMMONWEALTH UNIVERSITY (US) 2020-12-29 US disclosed
US-10875834-B2 Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives VIRGINIA COMMONWEALTH UNIVERSITY (US) 2020-12-29 US disclosed
CN-107501215-B Method and device for continuously preparing 5-hydroxymethylfurfural and derivatives thereof 中国农业大学 2020-10-30 CN disclosed
US-20200331879-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE EASTMAN CHEMICAL COMPANY (US) 2020-10-22 US disclosed
US-10723712-B2 Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant EASTMAN CHEMICAL COMPANY (US) 2020-07-28 US disclosed
US-20120302769-A1 OXIDATION PROCESS TO PRODUCE A CRUDE AND/OR PURIFIED CARBOXYLIC ACID PRODUCT EASTMAN CHEMICAL COMPANY (US) 2012-11-29 US disclosed
US-8242293-B2 Method for the synthesis of organic acid esters of 5-hydroxymethylfurfural and their use FURANIX TECHNOLOGIES B.V. (NL) 2012-08-14 US disclosed
EP-2423205-A1 Conversion of carbohydrates to hydroxymethylfurfural (HMF) and derivatives Archer-Daniels-Midland Company (US) 2012-02-29 EP disclosed
CN-101896476-A Conversion of carbohydrates to Hydroxymethylfurfural (HMF) and derivatives ARCHER DANIELS MIDLAND CO 2010-11-24 CN disclosed
EP-2217584-A2 CONVERSION OF CARBOHYDRATES TO HYDROXY-METHYLFURFURAL (HMF) AND DERIVATIVES Archer Daniels Midland Company (US) 2010-08-18 EP disclosed
US-20090306415-A1 Method For The Synthesis Of Organic Acid Esters Of 5-Hydroxymethylfurfural And Their Use FURANIX TECHNOLOGIES B.V. (NL) 2009-12-10 US disclosed
WO-2009076627-A2 CONVERSION OF CARBOHYDRATES TO HYDROXY-METHYLFURFURAL (HMF) AND DERIVATIVES ARCHER DANIELS MIDLAND CO (US) 2009-06-18 WO disclosed
US-20090156841-A1 CONVERSION OF CARBOHYDRATES TO HYDROXYMETHYLFURFURAL (HMF) AND DERIVATIVES ARCHER DANIELS MIDLAND CO. 2009-06-18 US disclosed
EP-2001859-A1 METHOD FOR THE SYNTHESIS OF ORGANIC ACID ESTERS OF 5-HYDROXYMETHYLFURFURAL AND THEIR USE Furanix Technologies B.V (NL) 2008-12-17 EP disclosed
WO-2007104515-A1 METHOD FOR THE SYNTHESIS OF ORGANIC ACID ESTERS OF 5-HYDROXYMETHYLFURFURAL AND THEIR USE FURANIX TECHNOLOGIES B.V. (NL) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10875834-B2 Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives MTHFD1, MTHFD2, ADH5 ALDH1A1 27/4885TSHR 2756/4885SMN1; SMN2 384/4885
US-10882032-B2 Furan-2,5-dicarboxylic acid purge process DDC, PCCA, DPYD ALDH1A1 197/4885TSHR 4372/4885SMN1; SMN2 3059/4885
US-20200331879-A1 METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE DDC, ACACA, ACACB ALDH1A1 198/4885TSHR 3693/4885SMN1; SMN2 2932/4885
US-20090156841-A1 CONVERSION OF CARBOHYDRATES TO HYDROXYMETHYLFURFURAL (HMF) AND DERIVATIVES HPD, FOS, MCCC2 ALDH1A1 953/4885TSHR 3037/4885SMN1; SMN2 1252/4885
US-10723712-B2 Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant DDC, DLAT, FDFT1 ALDH1A1 127/4885TSHR 3251/4885SMN1; SMN2 4665/4885
US-20120302769-A1 OXIDATION PROCESS TO PRODUCE A CRUDE AND/OR PURIFIED CARBOXYLIC ACID PRODUCT PCCA, ODC1, DDO ALDH1A1 113/4885TSHR 4153/4885SMN1; SMN2 3051/4885
US-11655227-B2 Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant DDC, DLAT, FDFT1 ALDH1A1 127/4885TSHR 3251/4885SMN1; SMN2 4665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.